X. Shen

Trade-Off between Treatment of Early Prostate Cancer and Incidence of Advanced Prostate Cancer in the Prostate Screening Era

Ultracentral Thoracic Reirradiation Using 10 Fraction Stereotactic Body Radiation Therapy for Recurrent Non–small Cell Lung Cancer Tumors: Preliminary Toxicity and Efficacy Outcomes

Results of a phase I-II trial using tri-modality therapy in patients with post-prostatectomy high risk pathologic (p) T2-3N0M0 prostate cancer.

Ultra-Central Radiation of Sixty-Two Thoracic Tumors Using 10 Fraction Stereotactic Body Radiation Therapy(SBRT): Outcome and Toxicity Analysis

Preliminary updated results of a phase I/II trial using trimodality therapy in patients with post-prostatectomy high-risk pathologic (p) T2-3N0M0 prostate cancer.

Trimodality Therapy Is Tolerable and Feasible in Patients With Postprostatectomy High-Risk Pathologic (p) T2-3N0M0 Prostate Cancer: Results of a Phase 1-2 Trial

Modeling of Tumor Control Probability and Rib Toxicity for Peripherally Located Non-Small Cell Lung Cancer (NSCLC) Lesions Treated With Monte Carlo–Based Dose Algorithm

The Correlation of Clinical Outcome and Radiobiological Modeling of Tumor Control Probability (TCP) in Patients With Lung Tumors Treated With SBRT Using the Monte Carlo–Based Dose Calculation Algorithm

On the Use of Intensity Modulated Arc Therapy for Whole-Brain Radiation Therapy With Hippocampal Avoidance and Simultaneous Integrated Boost for Multiple Brain Metastases.

Preliminary Results of a Nearly Completed Phase 1-2 Trial Using Trimodality Therapy in Patients With Post Prostatectomy High-Risk Pathologic (p) T2-3N0M0 Prostate Cancer